Hannafin J, Kinne-Saffran E, Friedman D, Kinne R
J Membr Biol. 1983;75(1):73-83. doi: 10.1007/BF01870801.
In order to investigate whether the loop diuretic sensitive, sodium-chloride cotransport system described previously in shark rectal gland is in fact a sodium-potassium chloride cotransport system, plasma membrane vesicles were isolated from rectal glands of Squalus acanthias and sodium and rubidium uptake were measured by a rapid filtration technique. In addition, the binding of N-methylfurosemide to the membranes was investigated. Sodium uptake into the vesicles in the presence of a 170 mM KCl gradient was initially about five-fold higher than in the presence of a 170 mM KNO3 gradient. In the presence of chloride, sodium uptake was inhibited 56% by 0.4 mM bumetanide and 40% by 0.8 mM N-methylfurosemide. When potassium chloride was replaced by choline chloride or lithium chloride, sodium uptake decreased to the values observed in the presence of potassium nitrate. Replacement of potassium chloride by rubidium chloride, however, did not change sodium uptake. Initial rubidium uptake into the membrane vesicles was about 2.5-fold higher in the presence of a 170 mM NaCl gradient than in the presence of a 170 mM NaNO3 gradient. The effect of chloride was completely abolished by 0.4 mM bumetanide. Replacement of the sodium chloride gradient by a lithium chloride gradient decreased rubidium uptake by about 40%; replacement by a choline chloride gradient reduced the uptake even further. Rubidium uptake was also strongly inhibited by potassium. Sodium chloride dependence and bumetanide inhibition of rubidium flux were also found in tracer exchange experiments in the absence of salt gradients. The isolated plasma membranes bound 3[H]-N-methylfurosemide in a dose-dependent manner. In Scatchard plots, one saturable component could be detected with an apparent KD of 3.5 x 10(-6) M and a number of sites n of 104 pmol/mg protein. At 0.8 microM, N-methylfurosemide binding decreased 51% when sodium-free or low-potassium media were used. The same decrease was observed when the chloride concentration was increased from 200 to 600 mM or when 600 1 mM bumetanide or furosemide was added to the incubation medium. These studies indicate that the sodium-chloride cotransport system described previously in the rectal gland is in fact a sodium-potassium chloride cotransport system. It is postulated that this transport system plays an essential role in the secondary active chloride secretion of the rectal gland.
为了研究先前在鲨鱼直肠腺中描述的对袢利尿剂敏感的氯化钠共转运系统实际上是否为钠-钾-氯化物共转运系统,从棘鲨的直肠腺中分离出质膜囊泡,并通过快速过滤技术测量钠和铷的摄取。此外,还研究了N-甲基速尿与膜的结合。在存在170 mM KCl梯度的情况下,囊泡对钠的摄取最初比存在170 mM KNO3梯度时高约五倍。在有氯离子存在的情况下,0.4 mM布美他尼可抑制钠摄取56%,0.8 mM N-甲基速尿可抑制40%。当氯化钾被氯化胆碱或氯化锂取代时,钠摄取量降至在硝酸钾存在下观察到的值。然而,用氯化铷取代氯化钾并没有改变钠摄取。在存在170 mM NaCl梯度的情况下,膜囊泡对铷的初始摄取比存在170 mM NaNO3梯度时高约2.5倍。0.4 mM布美他尼可完全消除氯离子的作用。用氯化锂梯度取代氯化钠梯度使铷摄取量降低约40%;用氯化胆碱梯度取代则使摄取量进一步降低。在无盐梯度的示踪剂交换实验中也发现了铷通量对氯化钠的依赖性和布美他尼的抑制作用。分离出的质膜以剂量依赖的方式结合3[H]-N-甲基速尿。在Scatchard图中,可以检测到一个可饱和成分,其表观解离常数KD为3.5×10(-6) M,位点数量n为104 pmol/mg蛋白质。在0.8 microM时,当使用无钠或低钾培养基时,N-甲基速尿结合减少51%。当氯离子浓度从200 mM增加到600 mM或当向孵育培养基中加入600 1 mM布美他尼或速尿时,也观察到相同的减少。这些研究表明,先前在直肠腺中描述的氯化钠共转运系统实际上是钠-钾-氯化物共转运系统。据推测,该转运系统在直肠腺的继发性主动氯化物分泌中起重要作用。